CHMP Recommends Approval of Lilly and Incyte’s OLUMIANT (baricitinib) as the First and Only…
Eli Lilly and Company and Incyte announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT …
Read More...
Read More...
